Your browser doesn't support javascript.
loading
Programmed, intermittent boluses versus continuous infusion to the sciatic nerve - a non-inferiority randomized, controlled trial.
Behrend Christiansen, Claus; Herold Madsen, Mikkel; Rothe, Christian; Bretlau, Claus; Lundstrøm, Lars Hyldborg; Lange, Kai H W.
Affiliation
  • Behrend Christiansen C; Department of Anesthesia and Intensive Care, Nordsjaellands Hospital, University of Copenhagen, Hillerød, Denmark.
  • Herold Madsen M; Department of Anesthesia and Intensive Care, Nordsjaellands Hospital, University of Copenhagen, Hillerød, Denmark.
  • Rothe C; Department of Anesthesia and Intensive Care, Nordsjaellands Hospital, University of Copenhagen, Hillerød, Denmark.
  • Bretlau C; Department of Anesthesia and Intensive Care, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Lundstrøm LH; Department of Anesthesia and Intensive Care, Nordsjaellands Hospital, University of Copenhagen, Hillerød, Denmark.
  • Lange KHW; Department of Anesthesia and Intensive Care, Nordsjaellands Hospital, University of Copenhagen, Hillerød, Denmark.
Acta Anaesthesiol Scand ; 66(1): 114-124, 2022 01.
Article in En | MEDLINE | ID: mdl-34582037
ABSTRACT

BACKGROUND:

Trials comparing programmed, intermittent boluses (PIB) and continuous infusion in catheter-based nerve blocks found no analgesic differences. However, as these trials used equal doses of local anesthetic (LA), the time of action of each bolus was not accounted for. Therefore, the dose-sparing benefits of PIB may have been overlooked. We compared the analgesic effect of boluses administered in intervals resembling the time of action of each bolus with continuous infusion. We hypothesized that PIB provided non-inferior analgesia despite consuming less LA.

METHODS:

Eighty-one patients undergoing fore- and midfoot surgery receiving a catheter-based sciatic nerve block were randomized to ropivacaine 0.2% as PIB of 10 ml every 8th hour or as continuous infusion, 6 ml h-1 . All participants could also receive boluses of 10 ml every 4th hour as needed. A non-inferiority randomized controlled design was used. Primary outcome was pain (VAS, 0-100 mm) for 72 h using area under curve (AUC) calculation. We assumed a linear relationship between mean VAS and AUC-VAS and used a non-inferiority margin of VAS = 20 mm, corresponding to AUC-VAS = 1440 mm h.

RESULTS:

Mean difference in AUC-VAS was -416 mm h (95% CI -1076 to 244; p = .217) between continuous infusion (mean AUC-VAS 1206 mm h) and PIB (mean AUC-VAS 1621 mm h), establishing non-inferiority. Mean total LA consumption was significantly larger for continuous infusion compared to PIB ((468 ml (95% CI 458 to 478) vs. 136 ml (95% CI 123 to 148); p < 0.0001)).

CONCLUSIONS:

PIB provided non-inferior analgesia compared to continuous infusion for 72 postoperative hours despite using significantly less LA.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pain, Postoperative / Nerve Block Type of study: Clinical_trials Limits: Humans Language: En Journal: Acta Anaesthesiol Scand Year: 2022 Document type: Article Affiliation country: Dinamarca

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pain, Postoperative / Nerve Block Type of study: Clinical_trials Limits: Humans Language: En Journal: Acta Anaesthesiol Scand Year: 2022 Document type: Article Affiliation country: Dinamarca